Genpact (G) Cash & Equivalents (2009 - 2026)

Genpact has reported Cash & Equivalents for 18 years, with the latest figure at $517.4 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 21.99% year-over-year to $517.4 million in Q2 2026; TTM through Jun 2026 was $517.4 million, a 21.99% decrease from a year earlier, with the FY2025 full-year figure at $853.8 million, up 31.71% from the prior year.
• Cash & Equivalents was $517.4 million for Q2 2026 at Genpact, down from $578.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $1.0 billion in Q3 2024, with the low at $460.4 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $646.3 million, with a median of $580.9 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents tumbled 43.77% in 2022, then jumped 89.03% in 2024.
• Over 5 years, Cash & Equivalents stood at $646.8 million in 2022, then decreased by 9.76% to $583.7 million in 2023, then increased by 11.06% to $648.2 million in 2024, then surged by 31.71% to $853.8 million in 2025, then tumbled by 39.4% to $517.4 million in 2026.
• The last three Cash & Equivalents figures came in at $517.4 million (Q2 2026), $578.1 million (Q1 2026), and $853.8 million (Q4 2025), per Business Quant data.